# OnCo record advenchen-laboratories (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/advenchen-laboratories/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "advenchen-laboratories" ;
  schema:name "Advenchen Laboratories"@en ;
  schema:alternateName "Advenchen Laboratories, LLC"@en, "Advenchen"@en ;
  schema:description "Advenchen is the small Californian company that discovered anlotinib, the multi-kinase inhibitor that became one of China's most used cancer pills, and it leads late-stage trials of related compounds."@en ;
  schema:url <https://onco.cc/companies/advenchen-laboratories/>, <https://advenchen.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://advenchen.com>, <https://clinicaltrials.gov/search?lead=Advenchen%20Laboratories%2C%20LLC>, <https://www.wikidata.org/wiki/Q140046417> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/anlotinib/>, <https://onco.cc/drugs/al8326/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct03016819/>, <https://onco.cc/trials/nct05363280/>, <https://onco.cc/trials/nct07392736/> .